Globus Medical Inc.
GMED | NYSE
$80.19
+$2.14 (+2.74%)
Nov 2, 2026, 11:39 AM ET · Market open
Company Profile
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
Key Executives
| Name | Position |
|---|---|
| Keith W. Pfeil | Chief Executive Officer, President & Director |
| Kyle R. Klin | Senior Vice President & Chief Financial Officer |
| Brian J. Kearns | Senior Vice President of Business Development & Investor Relations |
| David C. Paul | Co-Founder & Executive Chairman |
| Kelly G. Huller | Executive Vice President, General Counsel & Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 16, 2026 | 4 | Filing |
| Sep 15, 2026 | 144 | Filing |
| Aug 19, 2026 | 4 | Filing |
| Aug 18, 2026 | 144 | Filing |
| Aug 06, 2026 | 10-Q | Quarterly Report |
| Aug 06, 2026 | 8-K | Current Report |
| Jul 28, 2026 | 4 | Filing |
| Jun 09, 2026 | 4 | Filing |
| Jun 08, 2026 | 4 | Filing |
| Jun 05, 2026 | 144 | Filing |
Globus Medical Inc.
| Country | United States |
| IPO Date | Aug 3, 2012 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 6,000 |
| CEO | Keith W. Pfeil |
Contact Details
2560 General Armistead Avenue Audubon,
Pennsylvania 19403-5214 United States
Stock Details
| Ticker Symbol | GMED |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001237831 |
| CUSIP Number | 379577208 |
| ISIN Number | US3795772082 |
| SIC Code | 3841 |
Recent News
- 5 hours ago / zacks.comWall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a Bet
- 5 hours ago / zacks.comWhy Globus Medical (GMED) is a Top Momentum Stock for the Long-Term
- 4 days ago / zacks.com2 Healthcare Technology Stocks for a Digital Health Boom
- 17 days ago / zacks.comGMED or AXGN: Which Is the Better Value Stock Right Now?
- 19 days ago / globenewswire.comGlobus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026
- 21 days ago / globenewswire.comGlobus Medical Schedules Third Quarter Earnings Release and Conference Call
- 26 days ago / zacks.comReasons to Add Globus Medical Stock to Your Portfolio Now
- 28 days ago / zacks.comZacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific
- 28 days ago / zacks.comHere's Why Globus Medical (GMED) is a Strong Value Stock
- 28 days ago / zacks.com3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes
Add to Watchlist
Select watchlists to add or remove GMED